Monster Beverage's (MNST) stock performance should scare investors, as the stock has fallen 20% in the last six months. Monster recently gave upbeat revenue estimates for the year, but TheStreet's Chris Laudani believes those estimates look high and that the energy drink business is slowing faster than expected. While Monster Beverage struck a long term deal with Coca-Cola (KO) more than a year and a half ago, the transaction hasn't done much for Monster's shareholders. The deal made Coke a preferred distributor in exchange for a stake in the company and some asset exchanges.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.